Dexcom receives FDA warning letter for two manufacturing sites
The warning letter follows inspections by the FDA at Dexcom’s manufacturing facilities in San Diego and Mesa, Ariz., and ...
DexCom CGM Sensor Sales to Continue Despite FDA Warning Letter
DXCM faces an FDA warning over manufacturing issues, but operations remain unaffected. However, supply-chain risks and rising ...
FOX21 News16d
Dexcom diabetes monitoring device facing national shortage
For thousands of people across the country, access to the Dexcom G7 sensor is strained because of a supply shortage. “With the Dexcom, I get a little bit of a break because I can just look at the ...
Dexcom receives FDA warning letter for two U.S. manufacturing facilities
Medical device maker Dexcom said it has received a warning letter from the U.S. Food and Drug Administration following ...
Dexcom receives warning letter based on FDA inspections of 2 plants
The company does not expect the warning letter to materially impact its manufacturing capacity, sales or ability to seek ...
Is DexCom, Inc. (DXCM) the Best Growth Stock Under $100 to Buy Now?
We recently published a list of 10 Best Growth Stocks Under $100 to Buy Now. In this article, we are going to take a look at ...
DexCom falls after warning letter from FDA related to quality concerns
DexCom said that on Tuesday it received a warning letter from the U.S. FDA following inspections at its facilities in San Diego, Calif., and Mesa, Ariz. related to concerns about manufacturing ...
DexCom receives warning letter from FDA, sees no impact to FY25 guidance
In a regulatory filing, DexCom (DXCM) disclosed that on March 4, the company received a warning letter from the U.S. FDA following inspections ...
Morningstar29d
Dexcom Earnings: Fourth Quarter Held Few Surprises, but Improved Operations Bode Well for 2025
With the salesforce ramping up and regulatory approval of the 15-day G7 sensor expected this year, we anticipate Dexcom can return to double-digit top and bottom-line growth in 2025. We think the ...